Browse > Article

Neonatal jaundice  

Lee, Sang Lak (Department of Pediatrics, Keimyung University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.1, 2006 , pp. 6-13 More about this Journal
Abstract
Jaundice is one of the most common gastrointestinal conditions found in neonatal period, and most jaundice is benign. But because of the possibility of bilirubin toxicity, every newborn infants must be examined to identify the development of severe hyperbilirubinemia. To prevent the development of severe hyperbilirubinemia, promote and support successful breast-feeding, perform a systemic assessment before discharge for the risk of severe hyperbilirubinemia, provide early and close follow-up program, and treat with phototherapy or exchange transfusion or other therapeutic modalities, if indicated, are recommended.
Keywords
Neonatal jaundice;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Stoll BJ, Kliegman RM. Jaundice and hyperbilirubinemia in the newborn. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson Textbook of Pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:592-9
2 Freeman J, Lesko SM, Mitchell AA, Epstein MF, Shapiro S. Hyperbilirubinemia following exposure to pancuronium bromide in newborns. Dev Pharmacol Ther 1990;14:209-15
3 Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clin Perinatol 1990;17:293-306   DOI
4 Maisels MJ. Jaundice. In : Avery GB, Fletcher MA, Mac- Donald MG, editors. Neonatology; pathophysiology & management of the newborn. 5th ed. Philadelphia : Lippincott Williams & Wilkins, 1999:765-819
5 Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Snmesoporphyrin. Pediatrics 1999;103:1-5   DOI   ScienceOn
6 Kappas A, Drummond GS, Munson DP, Marshall JR. Snmesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001;108:1374-7   DOI   ScienceOn
7 Cho YJ, Kim CS, Lee SL. The effect of high-dose intravenous immune globulin in the treatment of neonatal immune hemolytic jaundice unresponsive to phototherapy. Kor J Perinatol 1999;19:176-82   DOI
8 Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;3:CD003313
9 Rübo J, Albrecht K, Lasch P, Laufkötter E, Leititis J, Marsan D, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-7   DOI
10 Alkalay AL, Simmons CF. Hyperbilirubinemia guidelines in newborn infants. Pediatrics 2005;115:824-5   DOI   ScienceOn
11 Robertson A, Carp W, Broderson R. Bilirubin displacing effect effect of drugs used in neonatology. Acta Paediatr Scand 1991;80:1119-27   DOI
12 Gartner LM. Neonatal jaundice. Pediatr Rev 1994;15:422-32
13 Horiguchi T, Bauer C. Ethnic differences in neonatal jaundice; comparison of Japanese and Caucasian newborn infants. Am J Obstet Gynecol 1975;121:71-4   DOI
14 Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics 1986;78:837-43
15 Maisels MJ. Neonatal jaundice. In : Avery GB, editor. Neonatology.2nd ed. Philadelphia : JB Lippincott, 1981:484
16 Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Snprotoporphyrin. Pediatrics 1998;101:E1
17 Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 2001;344:581-90   DOI   ScienceOn
18 Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988; 81:485-97
19 Martinez JC, Maisels MJ, Otheguy L, Garcia H, Savorani M, Mogni B, et al. Hyperbilirubinemia in the breast-fed newborn : a controlled trial of four interventions. Pediatrics 1993;91:470-3
20 Maisels MJ. Jaundice. In : MacDonald MG, Mullett MD, Seshia MMK, editors. Avery's Neonatology; pathophysiology & management of the newborn. 6th ed. Philadelphia : Lippincott Williams & Wilkins, 2005:768-846
21 Grobler JM, Mercer MJ. Kernicterus associated with elevated predominantly direct-reacting bilirubin. S Afr Med J 1997;87:1146.
22 American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316   DOI
23 MacMahon JR, Stevenson DK, Oski FA. Physiologic jaundice. In : Taeusch HW, Ballard RA, editors. Avery's Diseases of the Newborn. 7th ed. hiladelphia : WB Saunders Co, 1998:1003-7
24 Semmekrot BA, de Vries MG, Gerrits GP, van Wieringen PM. Optimal breastfeeding to prevent hyperbilirubinemia in healthy, term newborns. Ned Tijdschr Geneeskd 2004;148: 2016-9
25 Lambert GH, Muraskas J, Anderson CL, Myers TF. Direct hyperbilirubinemia associated with chloral hydrate administration in the newborn. Pediatrics 1990;86:277-81
26 Ahn HS. Textbook of pediatrics. 8th ed. Seoul : Daehan Printing & Publishing Co, 2004:343
27 Sato K, Hara T, Kondo T, Iwao H, Honda S, Ueda K. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand 1991;80:163-6   DOI